D-0842-2020 Class II Terminated

Recalled by Pfizer Inc. — New York, NY

FDA drug recall D-0842-2020 was initiated by Pfizer Inc. on Feb 5, 2020 and is designated Class II. Reason for recall: Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection. The recall status is terminated (terminated Mar 8, 2021). Affected quantity: 128 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 19, 2020
Initiation Date
Feb 5, 2020
Termination Date
Mar 8, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
128 bottles

Product description

Caduet (amlodipine besylate/atorvastatin calcium) Tablets, 10 mg/10 mg*, 30-count bottle, Rx only, Distributed by: Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Germany, NDC 0069-2160-30.

Reason for recall

Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.

Distribution pattern

Nationwide in the USA.

Code information

Lot #: CY0963, Exp 07/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0842-2020
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0842-2020. Report a data issue: hello@regdatalab.com.